Rockwell Medical Inc
RMTI
Get informed when a big investor buys or sells
+ FollowMarket Cap$31.83M
Close$
$4.44
47% downside
Current Fair Value
47% downsideOvervalued by 47% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $31.83 Million |
|---|---|
| Enterprise Value | $35.60 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.5 |
| Beta | 1.64 |
| Outstanding Shares | 3,958,568 |
Return
| Return on Equity | -19715.45% |
|---|---|
| Return on Assets | -12237.14% |
| Return on Invested Capital | -4149.55% |
Valuation & Multiples
| P/E Ratio | -5.8 |
|---|---|
| PEG | 27.05 |
| Price to Sales | 0.0 |
| Price to Book Ratio | 1.05 |
| Enterprise Value to Revenue | 0 |
| Enterprise Value to EBIT | -0.02 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.4 |
| Debt to Equity | 0.41 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.23
Average shareholder expectationRevenue Estimate
$17.82 M
Average shareholder expectationNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$-0.13
Average shareholder expectationRevenue Estimate
$18.22 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 66.33% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 8.62%▼ 1.47% |
|---|---|
| Total Invested | $1.89M▼ 46.74% |
| Investors Holding | 34▼ 10.00% |
ESG Score
No data
About Rockwell Medical Inc
CEO: Russell Ellison